Tianyu Tang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Health literacy and urban-rural disparities: a cross-sectional study of access, adherence, and quality of life across the neurological spectrum.
Journal: Frontiers in public health
Published: January 02, 2026
AURKB-mediated phosphorylation of metabolic enzyme CD73 drives immune suppression and renal cell carcinoma progression.
Journal: Cell death and differentiation
Published: December 03, 2025
Suppression of ASNS expression by VHL-mediated ubiquitination hinders the progression of renal cell carcinoma through enhancing JUP expression and inhibiting PI3K-AKT and MAPK pathways.
Journal: International journal of biological sciences
Published: December 02, 2025
LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1.
Journal: Oncogene
Published: August 15, 2024
mRNA vaccines in disease prevention and treatment.
Journal: Signal transduction and targeted therapy
Published: January 10, 2023
Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner.
Journal: Nature communications
Published: September 09, 2022
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity.
Journal: Journal for immunotherapy of cancer
Published: June 27, 2022
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2022
One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: November 22, 2021
Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Journal: BMC medical genomics
Published: September 16, 2021
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.
Journal: Molecular cancer
Published: December 01, 2020
Last Updated: 09/26/2026